Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
LDLR- |
RCV000237150 | SCV000295701 | likely pathogenic | Familial hypercholesterolemia 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Centre de Génétique Moléculaire et Chromosomique, |
RCV000237150 | SCV000503424 | pathogenic | Familial hypercholesterolemia 1 | 2016-12-16 | criteria provided, single submitter | clinical testing | subject mutated among 2600 FH index cases screened = 1 |
Laboratory of Genetics and Molecular Cardiology, |
RCV000237150 | SCV000588613 | pathogenic | Familial hypercholesterolemia 1 | 2016-03-01 | criteria provided, single submitter | research | |
Invitae | RCV000819649 | SCV000960320 | pathogenic | Familial hypercholesterolemia | 2018-12-28 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 12 of the LDLR gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is present in population databases (rs778408161, ExAC 0.001%). This variant has been observed in several individuals affected with hypercholesterolemia (PMID: 7583548, 26927322). ClinVar contains an entry for this variant (Variation ID: 252070). Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525). For these reasons, this variant has been classified as Pathogenic. |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000237150 | SCV000606538 | pathogenic | Familial hypercholesterolemia 1 | no assertion criteria provided | research |